Lorvotuzumab

• Description :

  Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab) ) is a humanized monoclonal antibody that binds to CD56 (NCAM1) and can be used to synthesize the antibody-drug conjugate Lorvotuzumab mertansine.

• CAS Number :

  339306-30-8

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  Approximately 146.44 kDa.

• Molecular Formula :

  ——

• Notes :

  Research use only, not for human use.

• Receptor :

  ADC Antibody